Huntington Bank Completes Merger with Cadence Bank, Expanding Presence Across Texas and the South

Huntington Bancshares Incorporated’s Board of Directors appoints three new board members Huntington Bancshares Incorporated (Nasdaq: HBAN) today announced it has closed its merger with Cadence Bank, a regional bank headquartered in Houston, Texas and Tupelo, Mississippi. This strategic partnership accelerates Huntington’s growth initiatives across Texas and the South and brings immediate scale in Texas and […]

AccuTrade Launches a Single Solution for Smarter Appraisals and Inventory Management

New AccuTrade IMS Available at NADA 2026 Delivers Accurate Appraisals, Optimized Inventory Turn and Maximized Front-end Gross Profit on Every VIN AccuTrade®, a solution from Cars.com Inc. (NYSE: CARS) (d/b/a “Cars Commerce Inc.”), has unveiled new technology built to maximize gross profit in the used-car business. The new AccuTrade Inventory Management System (IMS) gives dealers

Noble Corporation plc to announce fourth quarter and full year 2025 results

Noble Corporation plc (“Noble” or the “Company”) (NYSE: NE) today announces plans to report financial results for the fourth quarter and full year 2025 on Wednesday, February 11, 2026 after the U.S. market close. The Company's earnings press release and accompanying earnings presentation will be available on the Noble website at www.noblecorp.com. Noble will host

Society Pass Incorporated, NusaTrip Incorporated and Gorilla Form Exclusive eSIM Partnership in Projected US$8.7 Billion Travel eSIM Market

(NASDAQ:SOPA),(NASDAQ:NUTR), JAKARTA, Indonesia, Feb. 02, 2026 (GLOBE NEWSWIRE) — Society Pass Incorporated (Nasdaq: SOPA) (the “Company“), Southeast Asia's next generation digital ecosystem, and its majority owned subsidiary, NusaTrip Inc (Nasdaq: NUTR) (“NusaTrip“), the leading Southeast Asia (“SEA”) and Asia-Pacific-based (“APAC”) integrated travel technology platform, today announce that NusaTrip has entered into an exclusive strategic technology

Palvella Therapeutics Announces Scientific Publication in Clinical and Experimental Dermatology Highlighting a Systematic Review of Real-World Statin Evidence and Persistent Treatment Gaps Resulting from the Lack of FDA-Approved Therapies in Porokeratosis

(NASDAQ:PVLA), Publication includes a systematic review of 24 studies describing off-label cutaneous application of statins in porokeratosis Preliminary case reports suggesting clinical benefit underscore unmet need for development of a standardized, FDA-approved statin therapy evaluated in rigorous, well-designed clinical trials WAYNE, Pa., Feb. 02, 2026 (GLOBE NEWSWIRE) — (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella or

North American Niobium Corp. Appoints Dr. Maximilian Drollner as Technical Advisor

(CNSX:NIOB),(CNSX:NIOB.CN),(Boerse Frankfurt – Freiverkehr:KS82.F),(OTC US:NIOMF),(Other OTC:NIOMF), Vancouver, British Columbia, Feb. 02, 2026 (GLOBE NEWSWIRE) — North American Niobium and Critical Minerals Corp. (CSE: NIOB) (FSE: KS82.F) (OTCQB: NIOMF) (“North American Niobium” or the “Company”) is pleased to announce the appointment of Dr. Maximilian Drollner as Technical Advisor to the Company. Dr. Drollner brings valuable experience,

Columbia Financial, Inc. Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2025

(NASDAQ:CLBK), FAIR LAWN, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) — Columbia Financial, Inc. (the “Company”) (NASDAQ: CLBK), the mid-tier holding company for Columbia Bank (“Columbia”), reported net income of $15.7 million, or $0.15 per basic and diluted share, for the quarter ended December 31, 2025, as compared to a net loss of $21.2 million, or

Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency

(NasdaqGM:WVE), WVE-006 is a first-in-class RNA editing therapeutic candidate designed to correct the root cause of disease for the 200,000 individuals in the U.S. and Europe living with AATD; no currently approved therapies address both lung and liver manifestations of this disease Wave plans to engage FDA on potential accelerated approval pathway for WVE-006, with

Base Carbon Announces First CORSIA-Eligible Tagged Credits and Sales

(Neo:BCBN.NE),(Neo:BCBN),(OTC US:BCBNF),(Other OTC:BCBNF), TORONTO, Feb. 02, 2026 (GLOBE NEWSWIRE) — Base Carbon Inc. (Cboe CA: BCBN) (OTCQX: BCBNF) with operations through its wholly-owned subsidiary, Base Carbon Capital Partners Corp. (“BCCPC“, together, with affiliates, “Base Carbon“, or the “Company“), is pleased to announce that the Rwanda Cookstoves Project (the “Project”) has received full eligibility and tagging

Winshear Gold Announces $2,500,000 Private Placement

(TSX-V:WINS), NOT FOR DISTRIBUTION IN THE U.S. VANCOUVER, British Columbia, Feb. 02, 2026 (GLOBE NEWSWIRE) — Winshear Gold Corp. (TSX-V: WINS) announces a non-brokered private placement of 25,000,000 Units at $0.10 per Unit for gross proceeds of $2,500,000. Each Unit comprises one common share and one half of one common share purchase warrant. Each full

Scroll to Top